| [1] | Nwaka S, Ridley R (2003) Virtual drug discovery and development for neglected diseases through public private partnership. Nat Rev Drug Disc 2: 919–828. doi: 10.1038/nrd1230
|
| [2] | Moran M (2005) A breakthrough in R&D for neglected diseases: new ways to get the drugs we need. PLoS Med 2: e302. doi:10.1371/journal.pmed.0020302.
|
| [3] | Moran M, Guzman J, Ropars A-L, McDonald A, Jameson N, et al. (2009) Neglected disease research and development: how much are we really spending? PLoS Med 6: e1000030. doi:10.1371/journal.pmed.1000030.
|
| [4] | Nwaka S, Ramirez B, Brun R, Maes L, Douglas F, et al. (2009) Advancing drug innovation for neglected diseases - criteria for lead progression. PLoS Negl Trop Dis 3: e440. doi:10.1371/journal.pntd.0000440.
|
| [5] | Nwaka S, Hudson A (2006) Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 5: 941–955. doi: 10.1038/nrd2144
|
| [6] | BioVentures for Global Health (2007) Closing the global health innovation gap: a role for the biotechnology industry in drug discovery for neglected diseases. Available: http://www.bvgh.org/LinkClick.aspx?filet？icket=3An6aKB2z6Y%3D&tabid=79. Accessed 24 August 2011.
|
| [7] | Callan B, Gillespie I (2007) The path to new medicines. Nature 449: 164–165. doi: 10.1038/449164a
|
| [8] | Munos BH, Chin WW (2009) A call for sharing: adapting pharmaceutical research to new realities. Sci Transl Med 1: 9cm8. doi: 10.1126/scitranslmed.3000155
|
| [9] | Zerhouni EA (2009) Peer-to-peer sharing spurs scientific innovation. Sci Transl Med 1: 9ed2. doi: 10.1126/scitranslmed.3000584
|
| [10] | World Health Assembly (2008) World Health Assembly resolution (WHA 61.21) on the global strategy and plan of action on public health, innovation and intellectual property. Available: http://apps.who.int/gb/ebwha/pdf_files/A？61/A61_R21-en.pdf. Accessed 24 August 2011.
|
| [11] | Mboya Okeyo T, Ridley R, Nwaka S (2009) The African network for drugs and diagnostics innovation. Lancet 371: 1507–1508. doi: 10.1016/S0140-6736(09)60838-2
|
| [12] | ANDI (2009) Strategic and business plan for the African Network for Drugs and Diagnostics Innovation (ANDI). Available: http://meeting.tropika.net/andi2009/file？s/2009/10/sbp-final_web.pdf. Accessed 24 August 2011.
|
| [13] | Nwaka S, Ilunga TB, Da Silva JS, Rial Verde E, Hackley D, et al. (2010) Developing ANDI: a novel approach to health product R&D in Africa. PLoS Med 7: e1000293. doi:10.1371/journal.pmed.1000293.
|
| [14] | Aksoy S (2010) Solutions to neglected tropical diseases require vibrant local scientific communities. PLoS Negl Trop Dis 4: e662. doi:10.1371/journal.pntd.0000662.
|
| [15] | Hopkins AL, Witty MJ, Nwaka S (2007) Mission possible. Nature 449: 166–169. doi: 10.1038/449166a
|
